Clinical Trials Logo

Cognitive Impairment clinical trials

View clinical trials related to Cognitive Impairment.

Filter by:

NCT ID: NCT03246269 Completed - Dementia Clinical Trials

Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)

MoCA-Norm
Start date: December 2016
Phase:
Study type: Observational

This observational cohort study in healthy volunteers establishes normative data for the German version of the Montreal Cognitive Assessment (MoCA) and investigates the possible impacts of demographics on the MoCA total score.

NCT ID: NCT03244488 Completed - Clinical trials for Cognitive Impairment

Mental Ability Challenge Study in Adults With and Without HIV

Start date: December 2015
Phase:
Study type: Observational

It is estimated that by 2016, nearly 50% of HIV-positive individuals in the US will be aged 50 or older, and up to 60% of those will experience some degree of cognitive impairment as they age. The purpose of this study is to evaluate the contribution of the neuronal cholinergic receptor system to the cognitive impairments seen in adults aging with chronic HIV Infection. By using anti-cholinergic challenge drugs to reversibly "stress" cognitive functioning, the investigators hope to understand whether the presence of the HIV virus in the brain impairs the neural system necessary for normal cognition, more than would be expected from normal cognitive aging.

NCT ID: NCT03237676 Completed - Clinical trials for Cognitive Impairment

The Effect of Cognitive Rehabilitation Therapy in Improving Cognitive Function of Attention Following Mild Traumatic Brain Injury

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This research is a randomised controlled study. The study hypothesis is cognitive rehabilitation for attention deficits following mild traumatic brain injury will improve patient's cognitive outcome, measured by neuropsychological and neuroimaging parameters. Participant recruitment is from University Malaya Medical Centre, Malaysia. All mild traumatic brain injury participants have to fulfil the study inclusion criteria and written consented for therapy. Control group receives existing patient-centred cognitive treatment whereas intervention group receives individualised structured cognitive rehabilitation therapy. The intervention begins at three months post injury and ends at six months post injury. Study outcome measurements are applied at pre and post treatment. This study was ethically approved by Medical Research Ethics Committee University Malaya Medical Centre (MREC ID NO: 2016928-4293).

NCT ID: NCT03236259 Completed - Clinical trials for Cognitive Impairment

The Effect of Berry Extract Administration on Cognitive Health

Start date: February 21, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of daily supplementation of Brainport for a period of 6 months on cognitive health.

NCT ID: NCT03225768 Completed - Stroke Clinical Trials

Guided Training for People With Cognitive Impairment

GTPCI
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Abstract Objective: Investigators examined the feasibility of applying a participation-focused strategy training intervention to community-dwelling adults with cognitive impairments following stroke and brain injury and evaluated its potential effect on participation. Method: Participants with a diagnosis of stroke or brain injury participated in this single-group, repeated-measures study. Participants received 1~2 sessions of strategy training intervention weekly for 8~18 sessions. Outcome measures included the Participation Measure--3 Domains, 4 Dimensions (PM-3D4D), the Canadian Occupational Performance Measure (COPM), and feasibility indicators (participants' recruitment, retention, attendance, engagement, comprehension, satisfaction, and intervention adherence).

NCT ID: NCT03220295 Completed - Clinical trials for Cognitive Impairment

Putative Cognitive Enhancer VU319

Start date: July 28, 2017
Phase: Phase 1
Study type: Interventional

This is a safety study of the molecule VU319 to ascertain pharmacokinetic and pharmacodynamic data and test cognitive enhancement in healthy volunteers.

NCT ID: NCT03218982 Completed - Clinical trials for Cognitive Impairment

Vietnamese Caregiver Intervention Study

Start date: May 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and implement a culturally-appropriate intervention to reduce stress in Vietnamese dementia caregivers. A pilot intervention will be done to test the feasibility and acceptability of the intervention in a community setting. This will be done by randomly assigning a family triad (primary caregiver, secondary caregiver, and their care recipient) into an active intervention or a control condition and monitoring findings at baseline, post-intervention, and at three months.The intervention will consist of multiple components -enhanced psycho-education that includes discussion of Alzheimer's Disease (AD) and cultural impacts on beliefs about dementia and caregiving, management of problem behaviors, facilitation of support seeking, and mindful Tai Chi. A secondary caregiver who the primary caregiver identifies as providing him/her with the most support will be invited to join all components, but the intervention will be flexible depending on caregivers' needs/preferences. The care recipient is not required to join the sessions but will be able to if he/she or the family wishes. During the intervention, community partners will provide respite care for the care recipient.

NCT ID: NCT03207048 Completed - Bipolar Disorder Clinical Trials

A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

This study will investigate the effect of Repetitive transcranial magnetic stimulation (rTMS) on cognition and long-term clinical outcomes of bipolar patients.

NCT ID: NCT03204526 Completed - Parkinson Disease Clinical Trials

Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

Start date: June 2015
Phase: N/A
Study type: Interventional

Prospective trial of low frequency deep brain stimulation of the ventral subthalamic nucleus to improve cognitive performance in patients with advanced Parkinson's disease. All study participants have undergone DBS implantation surgery as part of their routine care for motor manifestations of Parkinson's disease. In this study, a temporary low frequency period of stimulation will be applied to determine its effects on cognition.

NCT ID: NCT03196037 Completed - Clinical trials for Cognitive Impairment

Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors

Start date: December 5, 2017
Phase: N/A
Study type: Interventional

Purpose:To gather preliminary data and to determine the feasibility and acceptability of an 8-week Tai Chi intervention for adults cancer survivors (survivors) who report experiencing cognitive impairment, and to perform exploratory analyses to assess improvements in cognitive performance, health-related quality of life, brain activity, and blood-based biomarkers. Participants: Adult survivors (> 18 years old) who report experiencing cognitive impairment and are within 60 months of completion of chemotherapy for treatment of a breast cancer diagnosis. Procedures (methods): A single arm pre-/post-test non-randomized study design in adult cancer survivors (Enrollment goal N=15; current age ≥ 18 years, treatment completed within 60 months). Outcomes will be assessed at baseline and after the 8-week Tai Chi intervention, and consist of feasibility, acceptability, expectancy/credibility, health-related quality of life, cognitive performance, serum biomarkers, and brain activity.